Article Text

Download PDFPDF
Correlation of Swede score colposcopy scoring system and histopathological results in patients with high-risk HPV infection other than HPV16 and 18
  1. Murat Alan1,
  2. Ilker Gunyeli2,
  3. Murat Gultekin3,
  4. Muzaffer Sancı4 and
  5. Kunter Yuce5
  1. 1 Obstetrics and Gynecology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, Izmir, Turkey
  2. 2 Obstetrics and Gynecology, Suleyman Demirel University, Isparta, Turkey
  3. 3 Obstetrics and Gynecology, Hacettepe University, Faculty of Medicine, Ankara, Turkey
  4. 4 Gynecological Oncology, University of Health Sciences, Izmir Tepecik Training and Research Hospital, Izmir, Turkey
  5. 5 Obstetrics and Gynecology, Hacettepe University, Faculty of Medicine, Ankara, Turkey
  1. Correspondence to Dr Ilker Gunyeli, Gynecology and Obstetrics, Suleyman Demirel Universitesi, Isparta, Isparta 32000, Turkey; drilkergunyeli{at}yahoo.com

Abstract

Objective Triage with HPV genotyping has some caveats and debates for HPV positive cases other than 16 and 18. The Swede score colposcopic scoring system has not previously been evaluated in this group of patients.

Objective To use the Swede score colposcopic scoring system to compare scores and final histopathological results in women who have undergone colposcopy owing to infection with high risk-HPVs other than HPV16 and 18 and to establish new cut-off values to predict pre-malignant lesions in this group of patients.

Methods This study was conducted in 613 women undergoing colposcopic evaluation because of abnormal cervical cytology together with high-risk HPV infection. All patients referred were evaluated by an expert colposcopist, given a Swede score (using the Swede score colposcopic scoring system) by using five variables (acetowhiteness, margins plus surface, vessel pattern, lesion size, and iodine staining), and had at least one biopsy procedure (either colposcopically directed or by a loop electrical excision procedure). Sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio values, and receiver operating characteristic curves for each clinico-pathological variable to detect low-grade and high-grade squamous intra-epithelial lesions, and any squamous cell abnormality (low-grade + high-grade squamous intra-epithelial lesions) were evaluated individually.

Results Final histopathological results of the patients were normal in 53.2% of cases, low-grade lesions in 32.5% of cases, and high-grade lesions in 14.4% of cases. Swede score was ≥8 (median 7.97) for high-grade lesions and ≥5 (median 5.06) for low-grade lesions. The area under the curve values (95% CI) of Swede scores for low-grade and high-grade squamous intra-epithelial lesions, and low-grade + high grade lesions were 0.92, 0.98, and 0.96, respectively. A Swede score cut-off value ≥6 had a sensitivity, specificity, positive predictive value, negative predictive value, and likelihood ratios of 92%, 98%, 93%, 98%, and 50 (22.6 to 110.8), respectively, for high-grade lesions at the final pathology (P<0.001). One high-risk HPV type (except 16 and 18) was no better than another for calculating the median Swede score during colposcopy (P=0.43).

Conclusions The Swede score colposcopic scoring system appears to be a useful tool for evaluating atypical cervical cytology in women with high-risk HPV infection other than HPV types 16 and 18.

  • colposcopy
  • high-grade squamous inta-epithelial lesions
  • HPV testing
  • low-grade squamous inta-epithelial lesions
  • Pap test
  • Swede score colposcopic scoring system
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors MA contributed to the literature search, project development, data collection and interpretation, and revision of the article; IG contributed to the literature search, manuscript writing/editing, and project development; MG contributed to the project development, management data analysis, and statistical analysis; MS contributed to using the Swede scoring system; KY contributed to project development and statistical analysis.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Ethics approval T.C Suleyman Demirel Universitesi, Tıp Fakultesi Klinik Araştırmalar Etik Kurul Baskanligi, Toplanti tarihi: 05.03.2019, Karar No: 82.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.